API
< Back to all clusters
[HEALTH] · Italy, China · 9 sources

started · updated

Lombardy targets innovation to compete with China in clinical research

The Lombardy region is focusing on digital transformation, partnerships, and competitiveness to address a decline in European clinical research. According to 2025 EFPIA data, Europe's share of new clinical trials launched globally fell from 18% to 9% between 2013 and 2023, while China's share rose from 8% to 29%.

During a Clinical Research Forum in Bergamo, organized by the Bion life sciences cluster, stakeholders discussed regional policies, the role of ethical committees, and the implementation of clinical trial centers. Key topics included artificial intelligence, data governance, and the importance of patient involvement in study design.

Gianluca Vago, president of Bion, noted that clinical research is shifting toward other global regions and expressed concern regarding the slowing pace of research in Italy.

Entities

Bion · China · EFPIA · Gianluca Vago · Lombardy

Claims

What the coverage asserts, and how many sources carry each claim.